- Myocardial Perfusion Imaging in Breast Cancer Patients
-
Sioka C, Fotopoulos A
- KMID: 2511805
- J Breast Cancer.
- 2020 Aug;23(4):447-448.
- doi: 10.4048/jbc.2020.23.e43
-
- CITED
-
- Close
- SHARE
-
- Close
- Breast Cancer Risk Prediction in Korean Women: Review and Perspectives on Personalized Breast Cancer Screening
-
Kim DY, Park HL
- KMID: 2511793
- J Breast Cancer.
- 2020 Aug;23(4):331-342.
- doi: 10.4048/jbc.2020.23.e40
Due to an increasing proportion of older individuals and the adoption of a westernized lifestyle, the incidence rate of breast cancer is expected to rapidly increase within the next 10... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression and Role of Epithelial Membrane Proteins in Tumorigenesis of Hormone Receptor-Positive Breast Cancer
-
Cha YJ, Koo JS
- KMID: 2511798
- J Breast Cancer.
- 2020 Aug;23(4):385-397.
- doi: 10.4048/jbc.2020.23.e42
Purpose: Studies on the expression of epithelial membrane proteins (EMPs) in breast cancer have been rare and limited. In the present study, we aimed to evaluate the expression of EMP1,... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of Circulating Tumor DNA to Predict Neoadjuvant Therapy Effectiveness and Breast Cancer Recurrence
-
Hao S, Tian W, Zhao J, Chen Y, Zhang X, Gao B, He Y, Luo D
- KMID: 2511797
- J Breast Cancer.
- 2020 Aug;23(4):373-384.
- doi: 10.4048/jbc.2020.23.e41
Purpose: Real-time detection and intervention can be used as potential measures to markedly decrease breast cancer mortality. Assessment of circulating tumor DNA (ctDNA) may offer great benefits for the management... -
- CITED
-
- Close
- SHARE
-
- Close
- Hints from a Female Patient with Breast Cancer Who Later Presented with Cowden Syndrome
-
Wang WC, Hou TC, Kuo CY, Lai YC
- KMID: 2511802
- J Breast Cancer.
- 2020 Aug;23(4):430-437.
- doi: 10.4048/jbc.2020.23.e25
A 51-year-old woman presented with metachronous tumor development in bilateral breasts, thyroid, and endometrium. Additional signs and symptoms fulfilled the National Comprehensive Cancer Network criteria for Cowden syndrome. Immunohistochemistry showed... -
- CITED
-
- Close
- SHARE
-
- Close
- Hyperglycemia during Adjuvant Chemotherapy as a Prognostic Factor in Breast Cancer Patients without Diabetes
-
Ahn HR, Kang SY, Youn HJ, Jung SH
- KMID: 2511799
- J Breast Cancer.
- 2020 Aug;23(4):398-409.
- doi: 10.4048/jbc.2020.23.e44
Purpose: Breast cancer treatments, including chemotherapy, administered in combination with glucocorticoids can induce hyperglycemia. This study aimed to investigate the effect of hyperglycemia during adjuvant chemotherapy on the prognosis of... -
- CITED
-
- Close
- SHARE
-
- Close
- LncRNA DLG1-AS1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Downregulating miR-203
-
Li S
- KMID: 2511795
- J Breast Cancer.
- 2020 Aug;23(4):343-354.
- doi: Triple negative breast neoplasms
Purpose: The oncogenic role of long non-coding RNA (lncRNA) DLG1-AS1 has been studied in cervical cancer, but its involvement in triple negative breast cancer (TNBC) is unknown. Here, we aimed... -
- CITED
-
- Close
- SHARE
-
- Close
- Metachronous Sporadic Sextuple Primary Malignancies Including Bilateral Breast Cancers
-
Hwang KT, Kim MJ, Chu AJ, Park JH, Kim J, Lee JY, Choi IS, Park JH, Chang JH, Hwang KR
- KMID: 2511803
- J Breast Cancer.
- 2020 Aug;23(4):438-446.
- doi: 10.4048/jbc.2020.23.e21
Multiple primary malignancies are defined as the presence of more than one malignant neoplasm with a distinct histology occurring at different sites in the same individual. They are classified as... -
- CITED
-
- Close
- SHARE
-
- Close
- Updated Bayesian Network MetaAnalysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer
-
Li X, Yao L, Wang M, Wang M, Li X, Yu X, Guo J, Dong H, Sun X, Xu Y
- KMID: 2511800
- J Breast Cancer.
- 2020 Aug;23(4):410-429.
- doi: 10.4048/jbc.2020.23.e45
Purpose: Combining targeted agents with adjuvant chemotherapy prolongs survival in human epidermal growth factor receptor 2 (HER2)-positive breast cancer patients, but also increases the risk of adverse effects. The updated... -
- CITED
-
- Close
- SHARE
-
- Close
- MiR-183-5p Promotes Proliferation, Metastasis and Angiogenesis in Breast Cancer Cells through Negatively Regulating Four and a Half LIM Protein 1
-
Li Y, Zeng Q, Qiu J, Pang T, Ye F, Huang L, Zhang X
- KMID: 2511796
- J Breast Cancer.
- 2020 Aug;23(4):355-372.
- doi: 10.4048/jbc.2020.23.e47
Purpose: Four and a half LIM protein 1 (FHL1) is involved in breast cancer (BC) development, but the regulatory mechanism involved remain unclear. In the present study, we examined the... -
- CITED
-
- Close
- SHARE
-
- Close
